Real-time enrollment status for this prostate cancer clinical trial
Current Status
Active, Not Recruiting
Checked: April 18, 2026 at 12:24 AM UTC
| NCT Number | NCT06402331 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Prostate Cancer |
| Phase | Clinical Trial |
| Target Enrollment | 100 participants |
| Active Locations | 18 sites in the US |
| Sponsor | Fusion Pharmaceuticals Inc. |
| Last Updated on CT.gov | April 8, 2026 (1 week ago) |
As of April 18, 2026: Clinical trial NCT06402331 is currently active_not_recruiting participants. This clinical trial study for prostate cancer is not currently accepting new participants at 18 locations across the United States. The study is sponsored by Fusion Pharmaceuticals Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06402331 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 18 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06402331 was last updated 1 week ago (April 8, 2026). HelloStudys verifies this status automatically.